Avista Capital Partners has acquired Taconic Biosciences from H.I.G. Capital. Transaction terms were not disclosed.
Founded in 1952 and headquartered in Rensselaer, New York, Taconic Biosciences specializes in genetically engineered research models and services, specifically murine models for use in drug discovery research and non-clinical safety testing.
Founded in 2005, Avista Capital is a New York-based private equity firm with more than $8 billion invested in more than 40 growth-oriented healthcare businesses globally.
According to the LevinPro HC database, this was the 122nd Biotechnology transaction of 2022. This compares with 103 Biotechnology deals recorded between January 1, 2021, and November 3, 2021.
